Fosaprepitant 150 mg/5mL (Fosaprepitant dimeglumine INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION) 150 mg/5mL

Fosaprepitant 150 mg/5mL is a lyophilized powder for intravenous solution, used to prevent nausea and vomiting. This medication is commonly administered in clinical settings for chemotherapy-induced nausea and vomiting (CINV).

Strength

150 mg/5mL

Pack Size

1 VIAL, SINGLE-DOSE in 1 CARTON (16714-248-01) / 5 mL in 1 VIAL, SINGLE-DOSE

Manufacturer / TM Owner

NorthStar RxLLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Fosaprepitant 150 mg/5mL is primarily used to prevent nausea and vomiting caused by chemotherapy. It is often administered as part of a combination therapy to manage CINV. Patients may wonder, 'What is Fosaprepitant used for?' This medication is designed to provide relief from severe nausea and vomiting associated with cancer treatments.

Side Effects

Fosaprepitant 150 mg/5mL may cause common side effects such as fatigue, headache, and diarrhea. Some patients may experience dizziness or constipation. These effects can vary depending on individual health conditions and other medications being taken.

Precautions & Warnings

Fosaprepitant 150 mg/5mL should be handled with care and administered by healthcare professionals. It is important to follow the prescribed dosage and administration guidelines. Patients with a history of severe allergic reactions to similar medications should consult their healthcare provider before use.

Avoid Interactions

Fosaprepitant 150 mg/5mL may interact with other medications, including those metabolized by the liver's CYP3A4 enzyme. Patients should inform their healthcare provider about all medications they are taking, including over-the-counter drugs and supplements. Alcohol consumption should be avoided while using this medication.

Frequently Asked Questions

Fosaprepitant is used to prevent nausea and vomiting, particularly in patients undergoing chemotherapy.

Fosaprepitant is administered as an intravenous injection after reconstitution.

Common side effects may include fatigue, headache, diarrhea, dizziness, and constipation.

Fosaprepitant may interact with other medications, so it is important to consult a healthcare provider before combining it with other drugs.

Patients with a history of severe allergic reactions to similar medications should consult their healthcare provider before using Fosaprepitant.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.